BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 35525880)

  • 1. Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise.
    Singh AK; Singh SV; Kumar R; Kumar S; Senapati S; Pandey AK
    World J Hepatol; 2023 Jan; 15(1):1-18. PubMed ID: 36744169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Purine and Uric Metabolism Signature Predicting the Prognosis of Hepatocellular Carcinoma.
    Yang S; Zhang B; Tan W; Qi L; Ma X; Wang X
    Front Genet; 2022; 13():942267. PubMed ID: 35903353
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor Microenvironment: Necroptosis Switches the Subtype of Liver Cancer While Necrosis Promotes Tumor Recurrence and Progression.
    Ă–zdemir BH
    Exp Clin Transplant; 2023 Apr; 21(4):291-298. PubMed ID: 35297332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
    Wu C; Bai DS; Jiang GQ; Jin SJ
    World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-matrix interaction induces phenotypic switching in liver cancer cells.
    Yuan RH; Hsu CL; Jhuang YL; Liu YR; Hsieh TH; Jeng YM
    Hepatol Int; 2022 Jun; 16(3):562-576. PubMed ID: 35525880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
    Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
    Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Ding L; Ning S; Hu W; Xue Y; Yu S
    Oxid Med Cell Longev; 2022; 2022():6595989. PubMed ID: 36199423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.
    Xue TC; Zhang BH; Ye SL; Ren ZG
    Tumour Biol; 2015 Aug; 36(8):5891-9. PubMed ID: 25712376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2.
    Nakanuma S; Tajima H; Okamoto K; Hayashi H; Nakagawara H; Onishi I; Takamura H; Kitagawa H; Fushida S; Tani T; Fujimura T; Kayahara M; Ohta T; Wakayama T; Iseki S; Harada S
    Int J Oncol; 2010 Apr; 36(4):793-800. PubMed ID: 20198321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.
    Seok JY; Na DC; Woo HG; Roncalli M; Kwon SM; Yoo JE; Ahn EY; Kim GI; Choi JS; Kim YB; Park YN
    Hepatology; 2012 Jun; 55(6):1776-86. PubMed ID: 22234953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kruppel-like factor 15 induces the development of mature hepatocyte-like cells from hepatoblasts.
    Anzai K; Tsuruya K; Ida K; Kagawa T; Inagaki Y; Kamiya A
    Sci Rep; 2021 Sep; 11(1):18551. PubMed ID: 34535735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma.
    Huang SC; Liao SH; Su TH; Jeng YM; Kao JH
    Hepatol Int; 2021 Apr; 15(2):472-481. PubMed ID: 33544314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.
    Janssen SM; Moscona R; Elchebly M; Papadakis AI; Redpath M; Wang H; Rubin E; van Kempen LC; Spatz A
    Cell Death Discov; 2020; 6():1. PubMed ID: 32123577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
    Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K
    Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of FRA1 protein in tumors.
    Jiang X; Xie H; Dou Y; Yuan J; Zeng D; Xiao S
    Mol Biol Rep; 2020 Jan; 47(1):737-752. PubMed ID: 31612408
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.